位置:首页 > 蛋白库 > GCYB_PLAF7
GCYB_PLAF7
ID   GCYB_PLAF7              Reviewed;        3179 AA.
AC   Q8IDA0; Q9GVB8;
DT   02-JUN-2021, integrated into UniProtKB/Swiss-Prot.
DT   05-MAY-2009, sequence version 2.
DT   03-AUG-2022, entry version 117.
DE   RecName: Full=Guanylate cyclase beta {ECO:0000305};
DE            Short=PfGCbeta {ECO:0000303|PubMed:10747978};
DE            EC=4.6.1.2 {ECO:0000269|PubMed:10747978, ECO:0000269|PubMed:11703675, ECO:0000305|PubMed:18452584};
DE   AltName: Full=Guanylyl cyclase beta {ECO:0000303|PubMed:10747978};
GN   Name=GCbeta {ECO:0000303|PubMed:10747978};
GN   ORFNames=PF3D7_1360500 {ECO:0000312|EMBL:CAD52725.2};
OS   Plasmodium falciparum (isolate 3D7).
OC   Eukaryota; Sar; Alveolata; Apicomplexa; Aconoidasida; Haemosporida;
OC   Plasmodiidae; Plasmodium; Plasmodium (Laverania).
OX   NCBI_TaxID=36329 {ECO:0000312|Proteomes:UP000001450};
RN   [1] {ECO:0000312|EMBL:CAC05389.1}
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, CATALYTIC ACTIVITY, COFACTOR,
RP   AND DEVELOPMENTAL STAGE.
RX   PubMed=10747978; DOI=10.1074/jbc.m001021200;
RA   Carucci D.J., Witney A.A., Muhia D.K., Warhurst D.C., Schaap P., Meima M.,
RA   Li J.L., Taylor M.C., Kelly J.M., Baker D.A.;
RT   "Guanylyl cyclase activity associated with putative bifunctional integral
RT   membrane proteins in Plasmodium falciparum.";
RL   J. Biol. Chem. 275:22147-22156(2000).
RN   [2] {ECO:0000312|Proteomes:UP000001450}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=3D7 {ECO:0000312|Proteomes:UP000001450};
RX   PubMed=12368864; DOI=10.1038/nature01097;
RA   Gardner M.J., Hall N., Fung E., White O., Berriman M., Hyman R.W.,
RA   Carlton J.M., Pain A., Nelson K.E., Bowman S., Paulsen I.T., James K.D.,
RA   Eisen J.A., Rutherford K.M., Salzberg S.L., Craig A., Kyes S., Chan M.-S.,
RA   Nene V., Shallom S.J., Suh B., Peterson J., Angiuoli S., Pertea M.,
RA   Allen J., Selengut J., Haft D., Mather M.W., Vaidya A.B., Martin D.M.A.,
RA   Fairlamb A.H., Fraunholz M.J., Roos D.S., Ralph S.A., McFadden G.I.,
RA   Cummings L.M., Subramanian G.M., Mungall C., Venter J.C., Carucci D.J.,
RA   Hoffman S.L., Newbold C., Davis R.W., Fraser C.M., Barrell B.G.;
RT   "Genome sequence of the human malaria parasite Plasmodium falciparum.";
RL   Nature 419:498-511(2002).
RN   [3] {ECO:0000312|Proteomes:UP000001450}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=3D7 {ECO:0000312|Proteomes:UP000001450};
RX   PubMed=12368867; DOI=10.1038/nature01095;
RA   Hall N., Pain A., Berriman M., Churcher C.M., Harris B., Harris D.,
RA   Mungall K.L., Bowman S., Atkin R., Baker S., Barron A., Brooks K.,
RA   Buckee C.O., Burrows C., Cherevach I., Chillingworth C., Chillingworth T.,
RA   Christodoulou Z., Clark L., Clark R., Corton C., Cronin A., Davies R.M.,
RA   Davis P., Dear P., Dearden F., Doggett J., Feltwell T., Goble A.,
RA   Goodhead I., Gwilliam R., Hamlin N., Hance Z., Harper D., Hauser H.,
RA   Hornsby T., Holroyd S., Horrocks P., Humphray S., Jagels K., James K.D.,
RA   Johnson D., Kerhornou A., Knights A., Konfortov B., Kyes S., Larke N.,
RA   Lawson D., Lennard N., Line A., Maddison M., Mclean J., Mooney P.,
RA   Moule S., Murphy L., Oliver K., Ormond D., Price C., Quail M.A.,
RA   Rabbinowitsch E., Rajandream M.A., Rutter S., Rutherford K.M., Sanders M.,
RA   Simmonds M., Seeger K., Sharp S., Smith R., Squares R., Squares S.,
RA   Stevens K., Taylor K., Tivey A., Unwin L., Whitehead S., Woodward J.R.,
RA   Sulston J.E., Craig A., Newbold C., Barrell B.G.;
RT   "Sequence of Plasmodium falciparum chromosomes 1, 3-9 and 13.";
RL   Nature 419:527-531(2002).
RN   [4] {ECO:0000305}
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, AND ACTIVITY REGULATION.
RX   PubMed=11703675; DOI=10.1046/j.1365-2958.2001.02665.x;
RA   Muhia D.K., Swales C.A., Deng W., Kelly J.M., Baker D.A.;
RT   "The gametocyte-activating factor xanthurenic acid stimulates an increase
RT   in membrane-associated guanylyl cyclase activity in the human malaria
RT   parasite Plasmodium falciparum.";
RL   Mol. Microbiol. 42:553-560(2001).
RN   [5] {ECO:0000305}
RP   FUNCTION, CATALYTIC ACTIVITY, AND DOMAIN.
RX   PubMed=18452584; DOI=10.1111/j.1365-2958.2008.06267.x;
RA   Taylor C.J., McRobert L., Baker D.A.;
RT   "Disruption of a Plasmodium falciparum cyclic nucleotide phosphodiesterase
RT   gene causes aberrant gametogenesis.";
RL   Mol. Microbiol. 69:110-118(2008).
CC   -!- FUNCTION: Catalyzes the synthesis of the second messenger cGMP from GTP
CC       (PubMed:10747978, PubMed:11703675, PubMed:18452584). Regulates cGMP
CC       production in gametocytes; however, is dispensable for the initiation
CC       of gametogenesis (PubMed:18452584). Does not have adenylate cyclase
CC       activity (PubMed:10747978). {ECO:0000269|PubMed:10747978,
CC       ECO:0000269|PubMed:11703675, ECO:0000269|PubMed:18452584}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=GTP = 3',5'-cyclic GMP + diphosphate; Xref=Rhea:RHEA:13665,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:37565, ChEBI:CHEBI:57746; EC=4.6.1.2;
CC         Evidence={ECO:0000269|PubMed:10747978, ECO:0000269|PubMed:11703675,
CC         ECO:0000305|PubMed:18452584};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000305|PubMed:11703675};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000305|PubMed:10747978, ECO:0000305|PubMed:11703675};
CC       Note=Binds 2 magnesium ions per subunit (By similarity). Is also active
CC       with manganese (in vitro) (Probable). {ECO:0000250|UniProtKB:P30803,
CC       ECO:0000305|PubMed:10747978, ECO:0000305|PubMed:11703675};
CC   -!- ACTIVITY REGULATION: Basal guanylate activity of the recombinant
CC       guanylate cyclase domains 1 and 2 is not modulated by an increase in
CC       Ca(2+) levels or by the gametogenesis inducer xanthurenic acid.
CC       {ECO:0000269|PubMed:11703675}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000255}; Multi-pass membrane
CC       protein {ECO:0000255}.
CC   -!- DEVELOPMENTAL STAGE: During the blood stage, specifically expressed in
CC       gametocytes. {ECO:0000269|PubMed:10747978}.
CC   -!- DOMAIN: The N-terminus contains a P-type ATPase-like domain which is
CC       required for guanylate cyclase activity. {ECO:0000269|PubMed:18452584}.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the cation transport
CC       ATPase (P-type) (TC 3.A.3) family. Type IV subfamily. {ECO:0000305}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the adenylyl cyclase
CC       class-4/guanylyl cyclase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ249165; CAC05389.1; -; Genomic_DNA.
DR   EMBL; AL844509; CAD52725.2; -; Genomic_DNA.
DR   RefSeq; XP_001350316.2; XM_001350280.2.
DR   STRING; 5833.MAL13P1.301; -.
DR   PRIDE; Q8IDA0; -.
DR   EnsemblProtists; CAD52725; CAD52725; PF3D7_1360500.
DR   GeneID; 813865; -.
DR   KEGG; pfa:PF3D7_1360500; -.
DR   VEuPathDB; PlasmoDB:PF3D7_1360500; -.
DR   VEuPathDB; PlasmoDB:Pf7G8_130065100; -.
DR   VEuPathDB; PlasmoDB:PfCD01_130066200; -.
DR   VEuPathDB; PlasmoDB:PfDd2_130066400; -.
DR   VEuPathDB; PlasmoDB:PfGA01_130066700; -.
DR   VEuPathDB; PlasmoDB:PfGB4_130066500; -.
DR   VEuPathDB; PlasmoDB:PfGN01_130067300; -.
DR   VEuPathDB; PlasmoDB:PfHB3_130067000; -.
DR   VEuPathDB; PlasmoDB:PfIT_130065900; -.
DR   VEuPathDB; PlasmoDB:PfKE01_130066200; -.
DR   VEuPathDB; PlasmoDB:PfKH01_130064600; -.
DR   VEuPathDB; PlasmoDB:PfKH02_130063500; -.
DR   VEuPathDB; PlasmoDB:PfML01_110043200; -.
DR   VEuPathDB; PlasmoDB:PfSD01_130067300; -.
DR   VEuPathDB; PlasmoDB:PfSN01_130063600; -.
DR   VEuPathDB; PlasmoDB:PfTG01_130066300; -.
DR   HOGENOM; CLU_225548_0_0_1; -.
DR   InParanoid; Q8IDA0; -.
DR   OMA; NNNKYHH; -.
DR   PhylomeDB; Q8IDA0; -.
DR   Proteomes; UP000001450; Chromosome 13.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0004383; F:guanylate cyclase activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006182; P:cGMP biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; IEA:InterPro.
DR   CDD; cd07302; CHD; 2.
DR   Gene3D; 3.30.70.1230; -; 2.
DR   Gene3D; 3.40.50.1000; -; 1.
DR   InterPro; IPR001054; A/G_cyclase.
DR   InterPro; IPR023298; ATPase_P-typ_TM_dom_sf.
DR   InterPro; IPR008250; ATPase_P-typ_transduc_dom_A_sf.
DR   InterPro; IPR036412; HAD-like_sf.
DR   InterPro; IPR023214; HAD_sf.
DR   InterPro; IPR029787; Nucleotide_cyclase.
DR   InterPro; IPR032630; P_typ_ATPase_c.
DR   Pfam; PF00211; Guanylate_cyc; 2.
DR   Pfam; PF16212; PhoLip_ATPase_C; 1.
DR   SMART; SM00044; CYCc; 2.
DR   SUPFAM; SSF55073; SSF55073; 2.
DR   SUPFAM; SSF56784; SSF56784; 1.
DR   SUPFAM; SSF81653; SSF81653; 1.
DR   SUPFAM; SSF81665; SSF81665; 1.
DR   PROSITE; PS50125; GUANYLATE_CYCLASE_2; 2.
PE   1: Evidence at protein level;
KW   cGMP biosynthesis; Glycoprotein; Lyase; Magnesium; Membrane; Metal-binding;
KW   Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN           1..3179
FT                   /note="Guanylate cyclase beta"
FT                   /id="PRO_0000452806"
FT   TOPO_DOM        1..60
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        61..81
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        82..88
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        89..109
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        110..295
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        296..316
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        317..328
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        329..349
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        350..988
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        989..1009
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1010..1020
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1021..1041
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1042..1069
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1070..1090
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1091..1102
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1103..1123
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1124..1127
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1128..1148
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1149..1168
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1169..1189
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1190..1304
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1305..1325
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1326..1331
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1332..1352
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1353..1360
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1361..1381
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1382..1401
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1402..1422
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1423..1464
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1465..1485
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1486..1507
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1508..1528
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1529..2739
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        2740..2760
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        2761..2770
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        2771..2791
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        2792..2809
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        2810..2830
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        2831..2842
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        2843..2863
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        2864..2870
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        2871..2891
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        2892..2895
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        2896..2916
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        2917..3179
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   DOMAIN          1548..1700
FT                   /note="Guanylate cyclase 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00099"
FT   DOMAIN          2968..3102
FT                   /note="Guanylate cyclase 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00099"
FT   REGION          2123..2153
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2355..2379
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2576..2656
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2362..2376
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2587..2612
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2615..2643
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         2973
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00099"
FT   BINDING         2973
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00099"
FT   BINDING         2974
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00099"
FT   BINDING         3017
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00099"
FT   BINDING         3017
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00099"
FT   CARBOHYD        1383
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CARBOHYD        2768
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
FT   CONFLICT        2045
FT                   /note="F -> C (in Ref. 1; CAC05389)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2059..2064
FT                   /note="KKIEKK -> NKI (in Ref. 1; CAC05389)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2072
FT                   /note="N -> Y (in Ref. 1; CAC05389)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2140
FT                   /note="K -> V (in Ref. 1; CAC05389)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2192
FT                   /note="F -> V (in Ref. 1; CAC05389)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2211
FT                   /note="K -> E (in Ref. 1; CAC05389)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        3128..3179
FT                   /note="Missing (in Ref. 1; CAC05389)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   3179 AA;  376990 MW;  D89AD593C4FBE547 CRC64;
     MKTQTLSLMN INGKRKFLGT NNKIYRKVII NPTSEDDIQK FCRNYFRIYN FSLYNFIRRL
     ISFDAILVYS LFLTVYIFSE INHGETKKYL FIDTAISLFF NIILLIVIES LFELKKLKDV
     KNANSQYYLR IVPKMSYFEK VMTKDIKVGN IIRIFQGDEF PADVVILYVK NNANAIVDSF
     KIDGLFRKSI KYAVDKYKID KDYLKMLSEI NGVIRCELPN KNIFCFQGNF KLDKHPRSLL
     LNYENFALQS SVLKGAEYID AVVVYTGADT KKNLNIPQKI EENKTFCIKM NNIVYYLIFM
     YFVFVVLSIV IKTIFFHKKN SFQNSRDSFL SMLEDFVGLY ILVLPIMMYS EKSLIYIIQS
     LRIENDLRMR NTDSEKPKVF NKNKNDSLGN VDLLATSRNG VLVKRKELLV SCVINNVMYG
     KKDIICSRTN FKLPTLNILD SERKNVSNLL NLDERIFKDP ENIFFPTRDF YSFLKLFENK
     ISSIYNPYSS SLSNLLKEKY KNYVNEEILN KNVKLTSFVK SQLTIGYNQI CEDDELSYNC
     YEIKEDSQKE NIQSVKIEDF ILGLCGCNRI IIYNEKSLDI SMNEYKSDNF METYSKFETE
     NEEYHENDHD EYHNMEHSDD ENINSIEYED ICLYNIIRNT GFSIYCYKNT LFLYNLMKEC
     KVYFLTCYHD FLRSNKFSMC ILKCGYSINN EKEGGILYVR GYDFNILPYI SKEKNNIKKI
     KNVIKIYTLN YLKVIILCKK QISNEDIAKY IILKSISKKL SFKFYDLIKL FFLYDLEVIG
     IIGLKNQLRE GVKETFNDVI NFDIKSWIFA NECSKDTYLT ALQCNLIVSS SNLFLINYYN
     LKNTHEEGAN ILFHNFISSL YKLKSNSYAV VINDESIKNI MTNVESMKIF LCIAMRATVV
     LFCKLQNETK GKIIRTLYAL TSPKLTVLGI GTTLNDAYLL KYSSISVFLS LNEHVNILYN
     ISDYVLQEFK FISELLILGR LNRFSLCKVF LWIIYLKITV VSFYFFHNFD NYFSGSSASS
     ILYTQTTFAL LHYFLIIAFS AYEIDLPYKF VRRLPYIYQL SRRKYFLNNN IILLTIIEAI
     LISLTSYYIL RLNVFHLITH REFTFHIFIL NVFITTEKIL LLSKTWHIYF FIMAVLIIGI
     LLIYVNIFTL VDCIKNGKCE FSLFQMENIY FWTSLFPILY INFIFDKLMK YIKNRIYPDI
     SDYLRKYFLR RICCHNNDKF LSQRKIKGIN KFVNFEKNDI LLKYIPTPKI YKIKDDPTYY
     NKSKRSKFLY DTFRKVIDIN VKYRNQQLNL EYKTYEKGNK LKLRIIVILL FLIYIIIFSS
     QTIIDINTKS NIHYITMFYI IYFVLACVLL IYIRIRNKAT STFFFFLSRF LLICGFCIEL
     YDNISNDILN VLITYSFTVS YIFFMSFKIL EALLVCISIL LLTFGVYYEK NKNMIDICTH
     FCSNPYLSIN NLDHMNISCL CKKQIVIFLI SLLSFTLICL SMKYYEIFYL KKKFLFRYKQ
     KVNLAKQIEI LHTMLPNFLV EYLLISDPKN DGIMVGKNIS GEDRGIISVI FCDIDDFQNM
     VSTLQPHVLV ETLDNLYLYF DKCIKYFNCI KIETVFESYL AASGLSEKKN NALDKIMYDT
     KCAIKLAIAQ LSAKYYISYK VLDTREHFSD NSTSYDKYIN KNISLKIGIH TGKAISGVIG
     SVKPQYALFG DTVNTASRMK STSLPDHIHV SYDTYKYLKE DNTFIWKERK VFIKGKGKMK
     TYLLVDILDD VKRKGESLNY YSSSNLLLSQ LGSEAVSIYE EREDIKEGSM DIIKESSRDI
     IKEDSRDIIK EISTNISKSS SRNISKSSSR SISDIKEGQI IDKEDLIFKI NRMKNKIDSR
     YSKRIDKESR DKISDKTNHV LDEVVKHSDI HLLNYEINNK RCKKMKGDTN NENKLIGDIF
     NMYDKKIKYI YKKNYKSKSM ENISFIKHYR NTKYKKSDYL LLDNKGESKK FKRNTSYVLE
     SPLHLIGDIV DNNIKRKKKK KEIKTIVSDD MFTSPVNIKE YNYNEQERKK EIVGNLSYDK
     TKKIFPFIKF TKEGRIKKKK IEKKEKKEKK ENNNNFLYND DYSSYSSPKY GDNENNFVIK
     YIRERKDFQK KFDHPNFNFS KFLHNYNPMK NKNKNKKNNK NVRRNEYPNY TSSSKDGVSY
     NFLSDSLFSS DNEYSSDNEY SSDSEKYYKK RFKKNKKIIK FDDLFTKIYI KKKRLLQMNN
     YDVKGKGKKL KNKGMERNKT KYKNVNEITK MKYFVNNENR DHEVNKEDIS KSMQKYFLHI
     SKHKKEQIED KKKTHKYFHK NVECVYPYAG NNINHNFSRN EKRKYSINLY DHLDEQEKIK
     GKKKYFNKDK ELIGSINKQT ERKPKKKNKK NIENKKDKKK IRMITNKTKE KHSNSIISVE
     EQNMNHNNSL KKKEVNFTGK NEEYLNRANT NCSLGIKEME EDVYEFHSNN IYYNNQTSYS
     DDINNTTKLK GMGNNTNDIS KNKGKNKLGK KISFFSMNNK YHESEIMNEE DNKNMLNLTQ
     SQIINKDKYN YFTHCPSLKK KKSVFTKINN LFKNYFKSID VHEKFGFSKK FKFHSKDSDD
     IKGNNNKISK NRYNNNNNNN NSNYSNIDSG KYSHNNKKNH HHNNNKYHHH NNNKYHHHNN
     NKYHHQNNNY EKHHHSNNSR VMLSKGEKTE KNENVDYAYQ FDNYDKKLLK KLTSNLQLNK
     KNVKNFNMFY YKFNDEELEE EYTRNYYREI INIDLTKKLI IIFIFTEIFL SLCNIIELSF
     YEKKLRYNDS IVIIWLIRSI YLFIITYIWI ILKTKLKEYK NNSSKMMWTI FILNIFLCSW
     GIILIDLSCI HYSMLLGNKN ERALFFMKDA SELIICIQLI FIKNMLFKHK FFFFVFFYIF
     LIYSFSKLFS IHTCQTHICC SIILFISINI LYFWYSEYLD RIQFLVKRKR NRMEKISQDF
     LTKILPRQVL EEYQNDNLQL TYKHEKIAFL FADIVGFTKW SKTVSPKEVL KLLQKLISKI
     DKDTIKLGLY KLFTIGDAYV ATSQPNSSIT DESEALEGIL NILKLAKLIL HNINTIKIQF
     NKHDFNMRIG LHYGSCVGGI IGSVRIRYDM WGLDVLIANK IESNGIPGEI ICSEQFRHFF
     IQNEPQAKLN FWYYKSISIN DQDIKLYVIE DKNYEEDYDP KVIDYTTLLK LRQKKGLRS
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024